JP2020505322A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020505322A5 JP2020505322A5 JP2019531615A JP2019531615A JP2020505322A5 JP 2020505322 A5 JP2020505322 A5 JP 2020505322A5 JP 2019531615 A JP2019531615 A JP 2019531615A JP 2019531615 A JP2019531615 A JP 2019531615A JP 2020505322 A5 JP2020505322 A5 JP 2020505322A5
- Authority
- JP
- Japan
- Prior art keywords
- patent document
- international
- prior
- documents cited
- international publication
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000001953 Hypotension Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 231100000762 chronic effect Toxicity 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- HRLIOXLXPOHXTA-UHFFFAOYSA-N medetomidine Chemical compound C=1C=CC(C)=C(C)C=1C(C)C1=CN=C[N]1 HRLIOXLXPOHXTA-UHFFFAOYSA-N 0.000 description 1
- 229960002140 medetomidine Drugs 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762443174P | 2017-01-06 | 2017-01-06 | |
| US62/443,174 | 2017-01-06 | ||
| PCT/US2018/012579 WO2018129313A1 (en) | 2017-01-06 | 2018-01-05 | Topical detomidine formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020505322A JP2020505322A (ja) | 2020-02-20 |
| JP2020505322A5 true JP2020505322A5 (OSRAM) | 2021-01-14 |
Family
ID=61054537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019531615A Pending JP2020505322A (ja) | 2017-01-06 | 2018-01-05 | 局所用デトミジン製剤 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20190343805A1 (OSRAM) |
| EP (1) | EP3565526B1 (OSRAM) |
| JP (1) | JP2020505322A (OSRAM) |
| KR (1) | KR20190110561A (OSRAM) |
| CN (1) | CN110114059A (OSRAM) |
| AU (1) | AU2018205217B2 (OSRAM) |
| BR (1) | BR112019011961A2 (OSRAM) |
| CA (1) | CA3049389A1 (OSRAM) |
| DK (1) | DK3565526T3 (OSRAM) |
| ES (1) | ES2982022T3 (OSRAM) |
| HU (1) | HUE068070T2 (OSRAM) |
| IL (1) | IL266448B2 (OSRAM) |
| MX (1) | MX382949B (OSRAM) |
| PL (1) | PL3565526T3 (OSRAM) |
| WO (1) | WO2018129313A1 (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210137830A1 (en) * | 2018-07-11 | 2021-05-13 | Clexio Biosciences Ltd. | Topical detomidine formulations |
| US20210323929A1 (en) * | 2018-07-18 | 2021-10-21 | Clexio Biosciences Ltd. | Purified Detomidine, Process of Preparing and Methods of Use |
| WO2020222192A1 (en) | 2019-05-01 | 2020-11-05 | Clexio Biosciences Ltd. | Methods of treating pruritus |
| WO2020222188A1 (en) | 2019-05-01 | 2020-11-05 | Clexio Biosciences Ltd. | Methods of treating pruritus |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10256774A1 (de) * | 2002-12-05 | 2004-06-24 | Lts Lohmann Therapie-Systeme Ag | Transmucosale und transdermale Arzneimittel mit verbesserter Wirkstoffresorption |
| FI20041425A0 (fi) * | 2004-11-05 | 2004-11-05 | Orion Corp | Transmukosaalinen veterinäärinen koostumus |
| US20130029989A1 (en) * | 2010-04-15 | 2013-01-31 | The Royal Institution For The Advancement Of Learning/Mcgill University | Topical treatments for pain |
| WO2013076160A1 (en) * | 2011-11-21 | 2013-05-30 | Université Libre de Bruxelles | Sustained release formulations useful in the treatment of diseases |
| EP2803668A1 (en) * | 2013-05-17 | 2014-11-19 | Boehringer Ingelheim International Gmbh | Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles |
| EP3033427A4 (en) * | 2013-08-14 | 2017-05-31 | The Board Of Trustees Of The University Of the Leland Stanford Junior University | Compositions and methods for controlling pain |
| US20150057351A1 (en) * | 2013-08-22 | 2015-02-26 | Sucampo Ag | Method for treating neuropathic pain |
-
2018
- 2018-01-05 US US16/475,452 patent/US20190343805A1/en not_active Abandoned
- 2018-01-05 IL IL266448A patent/IL266448B2/en unknown
- 2018-01-05 WO PCT/US2018/012579 patent/WO2018129313A1/en not_active Ceased
- 2018-01-05 AU AU2018205217A patent/AU2018205217B2/en active Active
- 2018-01-05 MX MX2019008115A patent/MX382949B/es unknown
- 2018-01-05 CA CA3049389A patent/CA3049389A1/en active Pending
- 2018-01-05 CN CN201880005492.XA patent/CN110114059A/zh active Pending
- 2018-01-05 EP EP18701853.6A patent/EP3565526B1/en active Active
- 2018-01-05 PL PL18701853.6T patent/PL3565526T3/pl unknown
- 2018-01-05 JP JP2019531615A patent/JP2020505322A/ja active Pending
- 2018-01-05 KR KR1020197023046A patent/KR20190110561A/ko not_active Ceased
- 2018-01-05 HU HUE18701853A patent/HUE068070T2/hu unknown
- 2018-01-05 BR BR112019011961-2A patent/BR112019011961A2/pt not_active IP Right Cessation
- 2018-01-05 ES ES18701853T patent/ES2982022T3/es active Active
- 2018-01-05 DK DK18701853.6T patent/DK3565526T3/da active
-
2023
- 2023-01-30 US US18/161,215 patent/US20230172909A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019502892A5 (OSRAM) | ||
| JP2020505322A5 (OSRAM) | ||
| JP2020530380A5 (OSRAM) | ||
| JP2013540292A5 (OSRAM) | ||
| EP4248973A3 (en) | Pyridazinone compounds and uses thereof | |
| JP2021504430A5 (OSRAM) | ||
| CN110139865A (zh) | Fgfr抑制剂 | |
| NO20082768L (no) | Levodopa prodroge mesylat, sammensetninger og anvendelser derav | |
| CL2020002597A1 (es) | Métodos para preparar composiciones proteicas estables | |
| CN112543755A (zh) | 一类细胞坏死抑制剂及其制备方法和用途 | |
| EP3752486A4 (en) | Heptamethine cyanines for use as fluorescent markers of the biliary and renal systems | |
| JP2019516789A5 (OSRAM) | ||
| EA202091478A1 (ru) | Антитела | |
| JP2020512939A5 (OSRAM) | ||
| MX2019008171A (es) | Inhibidores del antiporte mediado por nhe. | |
| CN114269751A (zh) | 光学纯的氧杂螺环取代的吡咯并吡唑衍生物、其制法与医药上的用途 | |
| CN113710671A (zh) | 作为布鲁顿酪氨酸激酶抑制剂的环状分子 | |
| JP2020500643A5 (OSRAM) | ||
| JP2021502362A5 (OSRAM) | ||
| JPWO2021108298A5 (OSRAM) | ||
| CN110461849A (zh) | 一种csf1r抑制剂及其制备方法和应用 | |
| JP2020523165A5 (OSRAM) | ||
| MA55507A (fr) | Macitentan destiné à être utilisé dans le traitement de l'hypertension portopulmonaire | |
| CN111836819A (zh) | 一种含有芳胺基取代的吡咯并嘧啶类化合物、制备方法及其应用 | |
| JP2020107131A5 (OSRAM) |